X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7867) 7867
Book Review (1149) 1149
Publication (308) 308
Magazine Article (29) 29
Book Chapter (22) 22
Newsletter (19) 19
Conference Proceeding (9) 9
Book / eBook (7) 7
Dissertation (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (6898) 6898
humans (6406) 6406
male (3459) 3459
female (3109) 3109
pseudomonas infections - etiology (2212) 2212
adult (2118) 2118
middle aged (1977) 1977
pseudomonas aeruginosa (1709) 1709
aged (1479) 1479
abridged index medicus (1427) 1427
pseudomonas aeruginosa - isolation & purification (1242) 1242
anti-bacterial agents - therapeutic use (1237) 1237
animals (1187) 1187
pseudomonas infections - drug therapy (1183) 1183
pseudomonas-aeruginosa (1174) 1174
adolescent (1033) 1033
child (932) 932
pseudomonas infections - complications (903) 903
infectious diseases (889) 889
microbiology (882) 882
infections (836) 836
pseudomonas infections - microbiology (739) 739
risk factors (707) 707
cystic fibrosis - complications (664) 664
respiratory system (649) 649
bacteria (646) 646
infection (623) 623
cystic fibrosis (622) 622
antibiotics (604) 604
child, preschool (601) 601
infant (565) 565
health aspects (546) 546
retrospective studies (538) 538
pseudomonas infections (521) 521
pseudomonas infections - diagnosis (521) 521
surgery (500) 500
pseudomonas aeruginosa - drug effects (486) 486
sepsis - etiology (470) 470
mice (445) 445
cross infection - etiology (441) 441
pseudomonas (438) 438
immunology (435) 435
aged, 80 and over (415) 415
pneumonia (414) 414
treatment outcome (409) 409
pediatrics (402) 402
pseudomonas infections - epidemiology (401) 401
research (396) 396
microbial sensitivity tests (395) 395
mortality (394) 394
time factors (390) 390
medicine, general & internal (377) 377
infant, newborn (366) 366
anti-bacterial agents - pharmacology (359) 359
prospective studies (354) 354
diagnosis (351) 351
anti-bacterial agents - administration & dosage (345) 345
pseudomonas aeruginosa - pathogenicity (344) 344
epidemiology (337) 337
care and treatment (326) 326
staphylococcal infections - etiology (308) 308
analysis (302) 302
pathogens (302) 302
pseudomonas - isolation & purification (298) 298
chronic disease (296) 296
ophthalmology (288) 288
cross infection - microbiology (287) 287
inflammation (287) 287
risk-factors (282) 282
children (277) 277
bacterial infections - etiology (275) 275
disease models, animal (274) 274
pharmacology & pharmacy (273) 273
biofilms (270) 270
bacteremia (265) 265
young adult (262) 262
pseudomonas infections - therapy (261) 261
pseudomonas infections - pathology (256) 256
burns - complications (253) 253
bacterial infections (251) 251
pneumonia - etiology (249) 249
cystic fibrosis - microbiology (248) 248
cystic-fibrosis (248) 248
research article (248) 248
cross infection - epidemiology (240) 240
medicine (232) 232
critical care medicine (231) 231
drug resistance, microbial (228) 228
respiratory tract infections - etiology (226) 226
sepsis (226) 226
therapy (225) 225
ventilator-associated pneumonia (223) 223
colonization (220) 220
management (219) 219
patients (219) 219
follow-up studies (218) 218
intensive care units (218) 218
virulence (218) 218
pseudomonas infections - prevention & control (217) 217
disease (213) 213
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6873) 6873
German (194) 194
French (176) 176
Spanish (169) 169
Russian (145) 145
Japanese (93) 93
Italian (67) 67
Polish (63) 63
Chinese (38) 38
Romanian (18) 18
Dutch (16) 16
Turkish (14) 14
Danish (13) 13
Portuguese (11) 11
Hungarian (6) 6
Slovak (6) 6
Hebrew (5) 5
Swedish (5) 5
Czech (4) 4
Norwegian (4) 4
Finnish (3) 3
Bulgarian (2) 2
Korean (2) 2
Lithuanian (2) 2
Serbian (2) 2
Ukrainian (2) 2
Afrikaans (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 2001, Volume 163, Issue 6, pp. 1371 - 1375
Although recommended durations of antimicrobial therapy for ventilator-associated pneumonia (VAP) range from 7 to 21 d, these are not based on prospective... 
DIAGNOSIS | ANTIBIOTIC USE | RESPIRATORY SYSTEM | PSEUDOMONAS-AERUGINOSA | INTENSIVE-CARE UNITS | NOSOCOMIAL PNEUMONIA | CRITICAL CARE MEDICINE | Recurrence | Enterobacteriaceae Infections - diagnosis | Prospective Studies | Humans | Middle Aged | Haemophilus Infections - blood | Male | Pneumococcal Infections - diagnosis | Haemophilus Infections - diagnosis | Pseudomonas Infections - blood | Respiration, Artificial - adverse effects | Time Factors | Pneumonia - diagnosis | Pneumonia - blood | Pneumococcal Infections - etiology | Risk Factors | Enterobacteriaceae Infections - etiology | Pseudomonas Infections - diagnosis | Cross Infection - drug therapy | Pneumococcal Infections - blood | Cross Infection - diagnosis | Bacterial Infections - blood | Cross Infection - blood | Enterobacteriaceae Infections - drug therapy | Practice Guidelines as Topic | Staphylococcal Infections - etiology | Pneumococcal Infections - drug therapy | Pseudomonas Infections - etiology | Cross Infection - etiology | Bacterial Infections - etiology | Infection Control - methods | Haemophilus influenzae | Bronchoalveolar Lavage Fluid - microbiology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Adult | Female | Leukocyte Count | Haemophilus Infections - drug therapy | Staphylococcal Infections - blood | Staphylococcal Infections - drug therapy | Pneumonia - etiology | Pseudomonas Infections - drug therapy | Proportional Hazards Models | Treatment Outcome | Haemophilus Infections - etiology | Staphylococcal Infections - diagnosis | Pneumonia - drug therapy | Enterobacteriaceae Infections - blood | Aged | Bacterial Infections - diagnosis | Drug Monitoring | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Journal Article
Diabetologia, ISSN 0012-186X, 5/2010, Volume 53, Issue 5, pp. 914 - 923
Skin and soft tissue infections (SSTIs) cause substantial morbidity in persons with diabetes. There are few data on pathogens or risk factors associated with... 
Medicine & Public Health | Human Physiology | Foot infections | Skin and soft tissue infection | Mortality | Metabolic Diseases | MRSA | Hospitalised patients | Internal Medicine | Diabetes | Length of stay | UNITED-STATES | RESISTANT STAPHYLOCOCCUS-AUREUS | COMPLICATED SKIN | SURGICAL SITE | ENDOCRINOLOGY & METABOLISM | DOUBLE-BLIND | ECONOMIC OUTCOMES | LARGE US DATABASE | EPIDEMIOLOGY | PATHOGENS | Pseudomonas Infections - economics | Soft Tissue Infections - etiology | Diabetes Complications - microbiology | Pseudomonas Infections - etiology | Prevalence | Length of Stay - economics | Staphylococcal Skin Infections - epidemiology | Humans | Risk Factors | Soft Tissue Infections - economics | Iatrogenic Disease - economics | Diabetes Complications - economics | Soft Tissue Infections - epidemiology | Diabetes Mellitus - microbiology | Pseudomonas - isolation & purification | Inpatients | Health Care Costs | Diabetes Mellitus - economics | Staphylococcal Skin Infections - etiology | Pseudomonas Infections - epidemiology | Diabetes Complications - epidemiology | Iatrogenic Disease - epidemiology | Methicillin-Resistant Staphylococcus aureus - isolation & purification | Staphylococcal Skin Infections - economics | Diabetics | Patient outcomes | Diabetic foot | Staphylococcus aureus infections | Risk factors | Medical care, Cost of | Medical colleges | Hospitals | Skin | Foot diseases | Index Medicus
Journal Article
Plastic and Reconstructive Surgery, ISSN 0032-1052, 04/2018, Volume 141, Issue 4, pp. 486e - 492e
BACKGROUND:Breast reconstruction with tissue expanders is the most common mode of reconstruction following mastectomy. Infection necessitating tissue expander... 
TISSUE EXPANDERS | SALVAGE | SURGERY | TOBRAMYCIN | SPARING MASTECTOMY | CAPSULAR CONTRACTURE | RISK | INFECTION | OUTCOMES | CALCIUM-SULFATE BEADS | BACTERIAL BIOFILMS | Pseudomonas Infections - etiology | Escherichia coli Infections - prevention & control | Humans | Middle Aged | Gentamicins - administration & dosage | Pseudomonas Infections - prevention & control | Drug Carriers | Anti-Bacterial Agents - therapeutic use | Microspheres | Tissue Expansion - methods | Mammaplasty - methods | Mastectomy | Adult | Female | Retrospective Studies | Drug Therapy, Combination | Escherichia coli Infections - etiology | Tissue Expansion Devices | Escherichia coli Infections - diagnosis | Surgical Wound Infection - epidemiology | Vancomycin - administration & dosage | Gentamicins - therapeutic use | Staphylococcus epidermidis - isolation & purification | Calcium Sulfate | Antibiotic Prophylaxis - methods | Pseudomonas Infections - diagnosis | Treatment Outcome | Tissue Expansion - instrumentation | Surgical Wound Infection - prevention & control | Escherichia coli Infections - epidemiology | Staphylococcal Infections - diagnosis | Staphylococcal Infections - epidemiology | Pseudomonas Infections - epidemiology | Vancomycin - therapeutic use | Surgical Wound Infection - diagnosis | Staphylococcal Infections - prevention & control | Aged | Anti-Bacterial Agents - administration & dosage | Staphylococcal Infections - etiology | Index Medicus | Abridged Index Medicus
Journal Article
Proceedings of the National Academy of Sciences, ISSN 0027-8424, 01/2013, Volume 110, Issue 3, pp. E250 - E259
Journal Article
Nature Medicine, ISSN 1078-8956, 04/2008, Volume 14, Issue 4, pp. 382 - 391
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2015, Volume 10, Issue 5, pp. e0127126 - e0127126
Background There are limited data describing the clinical characteristics of pyogenic spondylitis caused by Gram-negative bacteria (GNB). The aim of this study... 
DIAGNOSIS | MANAGEMENT | MULTIDISCIPLINARY SCIENCES | HEMATOGENOUS VERTEBRAL OSTEOMYELITIS | OUTCOMES | SPONDYLODISCITIS | EPIDEMIOLOGY | Sepsis - etiology | Cross Infection - etiology | Humans | Middle Aged | Male | Gram-Negative Bacterial Infections - microbiology | Cross Infection - pathology | Sepsis - pathology | Spondylitis - microbiology | Intraabdominal Infections - etiology | Spondylitis - pathology | Female | Retrospective Studies | Gram-Negative Bacterial Infections - pathology | Tertiary Care Centers | Intraabdominal Infections - microbiology | Risk Factors | Treatment Outcome | Gram-Positive Cocci - pathogenicity | Intraabdominal Infections - pathology | Cross Infection - microbiology | Gram-Negative Bacteria - pathogenicity | Spondylitis - etiology | Aged | Gram-Negative Bacterial Infections - etiology | Sepsis - microbiology | Complications and side effects | Spondylitis | Medical research | Gram-negative bacterial infections | Gram-positive bacterial infections | Medicine, Experimental | Comparative analysis | Risk factors | Laboratories | Physicians | Escherichia coli | Medical records | Infections | Arthritis | Epidemiology | Blood | Medical schools | Clinical outcomes | Pain | Etiology | Quality | Bacteria | Pseudomonas aeruginosa | Cocci | Trends | Gram-negative bacteria | Gram-positive cocci | Internal medicine | Mortality | Intra-abdominal infection | Risk analysis | Patients | Genitourinary tract | Medicine | Studies | Infectious diseases | Hospitals | Antibiotics | Sepsis | Index Medicus
Journal Article
European Respiratory Journal, ISSN 0903-1936, 03/2015, Volume 45, Issue 3, pp. 726 - 737
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2014, Volume 9, Issue 8, pp. e105854 - e105854
Journal Article
JAMA, ISSN 0098-7484, 10/2014, Volume 312, Issue 14, pp. 1447 - 1455
Journal Article